Is Bioasis Technologies Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Bioasis Technologies Inc (BTI.V) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Bioasis Technologies Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Bioasis Technologies Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Bioasis Technologies Inc?

Muslim investors may consider investing in Bioasis Technologies Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Bioasis Technologies Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Bioasis Technologies Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Bioasis Technologies Inc updated?

The Shariah compliance status of Bioasis Technologies Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Bioasis Technologies Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Bioasis Technologies Inc?

You can check the latest Shariah compliance status of Bioasis Technologies Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Bioasis Technologies Inc BTI.V

€0.01

Last Updated: Mar 18, 12:00 AM·MUN

Bioasis Technologies Inc. Stock Analysis BTI.V

Germany Health Care Nano Cap

biOasis Technologies, Inc. operates as a biopharmaceutical company. The company is headquartered in New Haven, Connecticut. The company went IPO on 2007-07-24. The firm is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). The company is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The firm is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

Key Statistics of Bioasis Technologies Inc (BTI.V)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.01€0.01

Today's Open

€0.01

Volume

5250.00

P/E Ratio (TTM)

52 Week Range

€0.01€0.19

Market Cap

6313.30

Avg. Volume

Dividend Yield

Financial Metrics & Statements of Bioasis Technologies Inc (BTI.V)

FAQ's for Bioasis Technologies Inc (BTI.V)

According to Musaffa’s Shariah screening methodology, Bioasis Technologies Inc (BTI.V) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.